The Impact of L4-L5 Minimally Invasive Transforaminal Lumbar Interbody Fusion on 2-Year Adjacent-level Parameters

被引:0
|
作者
Bakare, Adewale [1 ]
Alvarado, Anthony M. [2 ]
Coelho, Vicente [3 ]
Varela, Jesus R. [1 ]
Reine, Gibson J. [1 ]
Mazza, Jacob [1 ]
Fontes, Ricardo B. V. [1 ]
Deutsch, Harel [1 ]
O'Toole, John E. [1 ]
Fessler, Richard G. [1 ]
机构
[1] Rush Univ, Med Ctr, Dept Neurol Surg, Chicago, IL 60612 USA
[2] Univ Kansas, Med Ctr, Dept Neurosurg, Kansas City, KS USA
[3] Ohio State Univ, Wexner Med Ctr, Dept Neurol Surg, Coll Med, Columbus, OH USA
关键词
Adjacent level; Adjacent segment degeneration; Disc angle; Index level; Lumbar lordosis; Segmental lordosis; Transforaminal lumbar interbody fusion; RADIOGRAPHIC OUTCOMES; SEGMENT DISEASE; ALIGNMENT; LORDOSIS; CAGES;
D O I
10.1016/j.wneu.2024.07.041
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: This study evaluates the impact of L4-L5 minimally invasive surgery (MIS)- transforaminal lumbar interbody fusion (TLIF) on adjacent-level parameters. Methods: This is a retrospective study performed on consecutive patients between January 2015 and December 2019. The index- and adjacent-level segmental lordosis (SL) and disc angle (DA) were measured. Patient-reported outcomes (PROs) were collected preoperatively and at 3-24 months postoperatively. Factors influencing changes in adjacent-level parameters and the occurrence of adjacent segment degeneration (ASDeg) were assessed. Results: A total of 117 adult patients, averaging 65.5 years of age and slight preponderance of female (56.4%), were analyzed. L4-L5 SL decreased at 2 years (P < 0.05), but L4-L5 DA significantly increased at all timepoints (P < 0.05). While L3-L4 SL and DA significantly decreased at all timepoints (P < 0.05), L5-S1 SL decreased at 3 and 12 months (P < 0.05) and L5-S1 DA only significantly decreased at 2 years (P < 0.05). All PROs improved significantly (P < 0.0001). The ASDeg rate was 19.7% at 2.2 years. Cephalad and caudal ASDeg rates were 12.0% and 10.3%, respectively. Eight patients (6.8%) required adjacent-level reoperations, mainly at L3-L4 (6 cases). The use of expandable cage significantly reduced the odds of caudal ASDeg (OR 0.15, P = 0.037), but had no significant effect on cephalad ASDeg. Conclusions: L4-L5 MIS-TLIF had a more consistent effect on L3-L4 than L5-S1. Although adjacent-level SL and DA decreased over time, their association with ASDeg appears limited, suggesting a multifactorial etiology. L4-L5 MIS-TLIF provides demonstrable clinical benefits with lasting PRO improvements and low adjacent-level reoperations.
引用
收藏
页码:E109 / E120
页数:12
相关论文
共 50 条
  • [1] Two-Year Outcomes of Midline lumbar Fusion Versus Minimally Invasive Transforaminal Lumbar Interbody Fusion in the Treatment of L4-L5 Degenerative Disease
    WU Feng Liang
    DANG Lei
    ZHOU Hua
    YU Miao
    WEI Feng
    JIANG Liang
    LIU Zhong Jun
    LIU Xiao Guang
    Biomedical and Environmental Sciences, 2020, 33 (11) : 839 - 848
  • [2] Two-Year Outcomes of Midline lumbar Fusion Versus Minimally Invasive Transforaminal Lumbar Interbody Fusion in the Treatment of L4-L5 Degenerative Disease
    Liang, Wu Feng
    Lei, Dang
    Hua, Zhou
    Miao, Yu
    Feng, Wei
    Liang, Jiang
    Jun, Liu Zhong
    Guang, Liu Xiao
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2020, 33 (11) : 839 - 848
  • [3] Comparison of Minimally Invasive Lateral Lumbar Interbody Fusion, Minimally Invasive Lateral Lumbar Interbody Fusion, and Open Posterior Lumbar Interbody Fusion in the Treatment of Single-Level Spondylolisthesis of L4-L5
    Jang, Hae-Dong
    Lee, Jae Chul
    Seo, Jong-Hyeon
    Roh, Young-Ho
    Choi, Sung-Woo
    Shin, Byung-Joon
    WORLD NEUROSURGERY, 2022, 158 : E10 - E18
  • [4] Comparison of Minimally Invasive Lateral Lumbar Interbody Fusion, Minimally Invasive Transforaminal Lumbar Interbody Fusion, and Open Posterior Lumbar Interbody Fusion in the Treatment of Single-Level Spondylolisthesis of L4-L5 (vol 158, pg e10, 2021)
    Jang, Hae-Dong
    Lee, Jae Chul
    Seo, Jong-Hyeon
    Roh, Young-Ho
    Choi, Sung-Woo
    Shin, Byung-Joon
    WORLD NEUROSURGERY, 2022, 162 : 211 - 211
  • [5] Awake Robotic Minimally Invasive L4-5 Transforaminal Lumbar Interbody Fusion
    De Biase, Gaetano
    Chen, Selby
    Akinduro, Oluwaseun
    Quinones-Hinojosa, Alfredo
    Abode-Iyamah, Kingsley
    WORLD NEUROSURGERY, 2021, 148 : 93 - 93
  • [6] L5-S1 Transforaminal Lumbar Interbody Fusion is Associated With Increased Revisions Compared With L4-L5 Transforaminal Lumbar Interbody Fusion at Two Years
    Singh, Manjot
    Casey, Jack
    Glueck, Jacob
    Balmaceno-Criss, Mariah
    Perez-Albela, Alejandro
    Hanna, John
    Diebo, Bassel G.
    Daniels, Alan H.
    Basques, Bryce A.
    SPINE, 2025, 50 (05) : E79 - E84
  • [7] The Effect of Surgical Level on Self-Reported Clinical Outcomes After Minimally Invasive Transforaminal Lumbar Interbody Fusion: L4-L5 versus L5-S1
    Lawton, Cort D.
    Smith, Zachary A.
    Nixon, Alexander T.
    Dahdaleh, Nader S.
    Wong, Albert P.
    Khanna, Ryan
    Barnawi, Abdulwahed
    Fessler, Richard G.
    WORLD NEUROSURGERY, 2014, 81 (01) : 177 - 182
  • [8] Minimally invasive transforaminal and anterior lumbar interbody fusion surgery at level L5-S1
    Fidalgo, D. S.
    Areias, B.
    Sousa, L. C.
    Parente, M.
    Jorge, R. N.
    Sousa, H.
    Goncalves, J. M.
    COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING, 2020, 23 (08) : 384 - 395
  • [9] Long-Term Analysis of Adjacent Level Pathology in Minimally Invasive Transforaminal Lumbar Interbody Fusion
    Perez-Cruet, Mick J.
    Chieng, Lee Onn
    Elfallal, Wissam M.
    Mong, Eric
    Rapp, Aaron
    Elkhatib, Esam
    NEUROSURGERY, 2020, 67 : 265 - 266
  • [10] Outcome of posterior lumbar interbody fusion for L4-L5 degenerative spondylolisthesis
    Hayashi, Hiroyuki
    Murakami, Hideki
    Demura, Satoru
    Kato, Satoshi
    Kawahara, Norio
    Tsuchiya, Hiroyuki
    INDIAN JOURNAL OF ORTHOPAEDICS, 2015, 49 (03) : 284 - 288